INNT
TOTAL INVALIDATION PROCESSED BY THE IB
01/15/2022
Back to search
Official data from USPTO
BELIXOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
58
Latest update
01/15/2022
Trademark type
Word
Nice classes
5
Filing date
05/27/2009
Registration date
04/06/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2021
Last transaction
02/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
51377 Leverkusen, DE
Examiner
CORWIN, KEVIN
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH
Representatives
JENNIFER FRASER Dykema Gossett PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment and prevention of dermatological diseases and skin disorders; medicines for human purposespharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; medicines for veterinary purposespharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for medical purposespharmaceuticals for the treatment and prevention of dermatological diseases and skin disorders; chemical preparations for veterinary purposesmedicines for the treatment of dermatological diseases and skin disorders; topical ointment and gels for the medical and therapeutic treatment of dermatological diseases and skin disorders; * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of adverse effects of the treatment of cancer and leukemiain particular not for pharmaceutical preparations on the basis of mistletoe for the treatment of pre-cancerous lesionssolid tumorsmalignant hemoblastosesleukemiaslymphogranulomatosislymphomasplamacytomafor the stimulation of the bone marrow function and nutritional or dietary supplements * * all aforementioned goods not for the treatment of cancer and leukemia and the treatment of side-effects occurring during the treatment of cancer and leukemiaparticularly pharmaceutical preparations on the basis of mistletoes for the treatment of precancerous lesionssolid tumorsmalignant hemoblastosesleukemiaslymphogranulomatosislymphomasplasmacytomsfor stimulating the bone marrow functions and as nutritional supplements *
Publications
History of USPTO decisions and trademark events.
58 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
12/19/2021
INPC
INVALIDATION PROCESSED
12/18/2021
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/26/2021
C71T
CANCELLED SECTION 71
02/26/2021
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/13/2019
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/06/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/12/2017
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/12/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/08/2016
INPC
INVALIDATION PROCESSED
09/08/2016
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/08/2016
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/08/2016
71AG
REGISTERED-SEC.71 ACCEPTED
01/08/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/08/2016
ES71
TEAS SECTION 71 RECEIVED
11/28/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/28/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/27/2015
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
07/15/2015
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
03/24/2015
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/24/2014
PLGL
ASSIGNED TO PARALEGAL
07/24/2014
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
07/23/2014
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
07/04/2014
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/30/2014
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
06/04/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/07/2013
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
10/04/2012
PLGL
ASSIGNED TO PARALEGAL
10/04/2012
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
10/04/2012
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
09/28/2012
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/28/2010
FIMP
FINAL DISPOSITION PROCESSED
07/28/2010
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
07/28/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2010
PUBO
PUBLISHED FOR OPPOSITION
01/19/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/14/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2009
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/11/2009
ALIE
ASSIGNED TO LIE
12/11/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/24/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/24/2009
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/06/2009
RFNT
REFUSAL PROCESSED BY IB
09/29/2009
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
09/23/2009
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
09/18/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/04/2009
RFRR
REFUSAL PROCESSED BY MPU
09/04/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/04/2009
CNRT
NON-FINAL ACTION WRITTEN
09/03/2009
DOCK
ASSIGNED TO EXAMINER
08/27/2009
MAFR
APPLICATION FILING RECEIPT MAILED
08/11/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/06/2009
Continuous trademark protection
Get notified about every new filing that threatens BELIXOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.